Back
Amphastar Pharmaceuticals, Inc. 10K Form
Buy
55
AMPH
Amphastar Pharmaceuticals, Inc.
Last Price:
$30.81
Seasonality Move:
1.3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AMPH News And Ratings
See the #1 stock for the next 7 days that we like better than AMPH
AMPH Financial Statistics
Sales & Book Value
| Annual Sales: | $732M |
|---|---|
| Cash Flow: | $22.8M |
| Price / Cash Flow: | 14.01 |
| Annual Sales: | $16.29 |
| Price / Book: | 1.88 |
Profitability
| EPS (TTM): | 2.67000 |
|---|---|
| Net Income (TTM): | $134.7M |
| Gross Margin: | $361.4M |
| Return on Equity: | 18.29% |
| Return on Assets: | 8.52% |
Amphastar Pharmaceuticals, Inc. Earnings Forecast
Key Amphastar Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 22 years for AMPH is 49.37%.
-
The Selling, General & Administrative Expenses for AMPH have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 8.39% of Revenue.
-
The Interest Expense is 19.02% of Operating Income.
-
The Net Earning history of AMPH is 21.79% of Total Revenues.
-
Per Share Earnings over the last 22 years have been positive in 11 years.
Amphastar Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | AMPH |
| CUSIP: | 03209R |
| Website: | amphastar.com |
Debt
| Debt-to-Equity Ratio: | 0.87 |
|---|---|
| Current Ratio: | 3.29 |
| Quick Ratio: | 2.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 10.01 |
|---|---|
| Forward P/E Ratio: | 8.08 |
AMPH Technical Analysis vs Fundamental Analysis
Buy
55
Amphastar Pharmaceuticals, Inc. (AMPH)
is a Buy
Is Amphastar Pharmaceuticals, Inc. a Buy or a Sell?
-
Amphastar Pharmaceuticals, Inc. stock is rated a BuyThe current Amphastar Pharmaceuticals, Inc. [AMPH] share price is $30.62. The Score for AMPH is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.